Anne C. Dietz, PhD, MS, MSCE

Anne C. Deitz, PhD, MS, MSCE

Anne C. Deitz, PhD, MSCE, is currently the head of Oncology Epidemiology at Merck, and has more than 20 years of experience as an epidemiologist in the pharmaceutical industry. Her team conducts observational research to support primarily clinical trial planning and regulatory submissions through studies on disease epidemiology and natural history, biomarker prevalence and prognostic significance, surrogate/early endpoints, and post-approval safety and/or effectiveness. She and her team have supported approvals of KEYTRUDA, WELIREG, LYNPARZA, LENVIMA, KOSELUGO, and they continue to support new assets in development. While at Merck Anne has been recognized for leadership and support of KEYTRUDA ODAC preparations, leadership on the global multicenter EXPRESS study, and successful execution of an FDA requested post-authorization safety study, among other awards.                      

Anne holds a PhD in Pharmacology & Toxicology from the University of North Dakota School of Medicine; she earned her MS in Clinical Epidemiology in 2002 from the University of Pennsylvania’s Center for Clinical Epidemiology & Biostatistics, where she trained with Dr. Timothy Rebbeck.  

 


anne.deitz@merck.com

Dan T. Vogl, MD, MSCE

Dan T. Vogl, MD, MSCE

Associate Professor of Medicine
Division of Hematology and Oncology
University of Pennsylvania Perelman School of Medicine

 

Dr. Vogl’s research focus is on clinical trials of novel therapies plasma cell malignancies and specifically myeloma, with an emphasis on translational Phase I and II trials. He is the Director of the Abramson Cancer Center Clinical Research Unit, overseeing the work of over 90 research nurses, research coordinators, regulatory coordinators and biospecimen coordinators, who together manage over 300 active cancer clinical trials. Dr. Vogl has published in several high-impact journals such as the Cancer Research Communications and Clinical Cancer Research.

Dan.Vogl@pennmedicine.upenn.edu

 

 

Lucy Wolf Tuton, PhD

Lucy Wolf Tuton, PhD

Adjunct Professor of Medicine and Prevention & Population Health
University of Pennsylvania Perelman School of Medicine

 

Dr. Tuton serves as Executive Director of Bridging the Gaps, a program that links the training of health professionals with the provision of health-related service for vulnerable populations.  The program is jointly administered by eight academic health centers in the Commonwealth of Pennsylvania and one in New Jersey, who partner each year with over 100 community organizations serving vulnerable populations.  Dr. Tuton is also the Director of Professional Development for FOCUS on Health & Leadership for Women, a program promoting advocacy, education and research in women’s health and the advancement of women in academic medicine.  Due to her role in FOCUS, she was a Co–Investigator on the unique R01 funded NIH–TAC (Transforming Academic Culture) study.  Dr. Tuton also served as an Associate Director of the Perelman School of Medicine’s Robert Wood Johnson Clinical Scholars Program and at its conclusion, became an Associate Director for the National Clinician Scholars Program.  In this capacity, she co–directs a career development curriculum.  Due to her experience in professional and career development, Dr. Tuton co–directs other related initiatives focused on faculty and trainees, as well as on STEMM faculty across the university. 

 

Contact information

Blockley Hall, 912
423 Guardian Drive
Philadelphia, PA 19104

Office: 215 898-4440
Fax: 215 573-2265

Email:
tuton@upenn.edu

Education:
BA
Sarah Lawrence College, 1971.
MA (Human Development)
Bryn Mawr College, 1981.
PhD (Human Development (Psychology)
Bryn Mawr College, 1987.

Links
Penn Faculty Pathways Program
FOCUS on Health and Leadership for Women Program
The Bridging the Gaps Program

Aaron Richterman, MD, MPH

Aaron Richterman, MD, MPH

Assistant Professor
Division of Infectious Diseases
University of Pennsylvania Perelman School of Medicine

Dr. Richterman uses multiple research methodologies to evaluate the relationships between poverty, food security, and individual and population health outcomes.  He is interested in both non–experimental approaches to assessing the effects of poverty reduction and social protection programs on health outcomes, and in conducting hypothesis-driven research to design and evaluate innovative economic interventions to enable health behaviors and improve clinical outcomes.

aaron.richterman@pennmedicine.upenn.edu

Subscribe to